NIH study traces molecular link from gene to late-onset retinal degeneration
Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | Diabetes | Endocrinology | Fortamet | Genetics | Metformin | National Institutes of Health (NIH) | Study | Vitamin A